CPRX Catalyst Pharmaceuticals PE ratio, current and historical analysis
The current P/E ratio for Catalyst Pharmaceuticals stock as of Feb 4, 2025 is 18.47. This is calculated based on the current EPS of $1.25 and the stock price of $23.09 per share. The PE ratio has decreased by 21% from the past four quarters average of 23.5.
CPRX PE ratio history
The average historical PE ratio of Catalyst Pharmaceuticals for the last six years is 17.37. The current price-to-earnings ratio of 18.47 is 6% more than the historical average. In the past six years, CPRX's PE ratio reached its highest point in the Sep 2019 quarter at 59, when the stock price was $5.31 and the EPS was $0.09. The lowest point was recorded in the Sep 2020 quarter, when it reached 4.3 with a price of $2.97 and an EPS of $0.69.
Catalyst Pharmaceuticals PE ratio by year
Maximum annual increase: 284.05% in 2021
Maximum annual decrease: -61.65% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | 25.09 | 7.91% | $16.81 | $0.67 |
| 2022 | 23.25 | 30.47% | $18.6 | $0.8 |
| 2021 | 17.82 | 284.05% | $6.77 | $0.38 |
| 2020 | 4.64 | -61.65% | $3.34 | $0.72 |
| 2019 | 12.1 | N/A | $3.75 | $0.31 |
| 2018 | N/A | N/A | $1.92 | -$0.33 |
| 2017 | N/A | N/A | $3.91 | -$0.21 |
| 2016 | N/A | N/A | $1.05 | -$0.22 |
| 2015 | N/A | N/A | $2.45 | -$0.25 |
| 2014 | N/A | N/A | $2.97 | -$0.24 |
| 2013 | N/A | N/A | $1.95 | -$0.27 |
| 2012 | N/A | N/A | $0.44 | -$0.14 |
| 2011 | N/A | N/A | $1.29 | -$0.29 |
| 2010 | N/A | N/A | $0.99 | -$0.22 |
| 2009 | N/A | N/A | $0.63 | -$0.48 |
Catalyst Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 15.9 | -39.43% | $19.88 | $1.25 |
| Jun 2024 | 26.25 | -1.2% | $15.49 | $0.59 |
| Mar 2024 | 26.57 | 5.9% | $15.94 | $0.6 |
| Dec 2023 | 25.09 | 26.65% | $16.81 | $0.67 |
| Sep 2023 | 19.81 | 62.11% | $11.69 | $0.59 |
| Jun 2023 | 12.22 | -29.97% | $13.44 | $1.1 |
| Mar 2023 | 17.45 | -24.95% | $16.58 | $0.95 |
| Dec 2022 | 23.25 | 17.78% | $18.6 | $0.8 |
| Sep 2022 | 19.74 | 49.21% | $12.83 | $0.65 |
| Jun 2022 | 13.23 | -29.78% | $7.01 | $0.53 |
| Mar 2022 | 18.84 | 5.72% | $8.29 | $0.44 |
| Dec 2021 | 17.82 | 34.49% | $6.77 | $0.38 |
| Sep 2021 | 13.25 | 65.83% | $5.3 | $0.4 |
| Jun 2021 | 7.99 | 19.61% | $5.75 | $0.72 |
| Mar 2021 | 6.68 | 43.97% | $4.61 | $0.69 |
CPRX average PE ratio chart
The current PE ratio of CPRX is above its 5 and 10-year historical averages, but it is lower than the 3-year average.
CPRX PE vs peers
When compared to its peer stocks JNJ and ABT, CPRX's PE ratio is lower. Catalyst Pharmaceuticals is presently trading at a lower PE ratio (18.47) than its peer group average of 41.74.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CPRX Catalyst Pharmaceuticals Inc | 18.47 | $2.75B |
| JNJ Johnson & Johnson | 25.45 | $369.55B |
| PFE Pfizer Inc | 34.04 | $146.61B |
| BMRN Biomarin Pharmaceutical Inc | 36.98 | $11.98B |
| ABT Abbott Laboratories | 39.12 | $223.92B |
| SRPT Sarepta Therapeutics Inc | 73.13 | $10.9B |
Frequently asked questions
What is Catalyst Pharmaceuticals's PE ratio?
CPRX stock has a price to earnings ratio of 18.47 as of Feb 4, 2025.
What is the 3-year average PE ratio for Catalyst Pharmaceuticals (CPRX)?
As an average over the last 3 years, CPRX stock has a PE ratio of 19.85.
What is the 5-year average PE ratio for Catalyst Pharmaceuticals (CPRX)?
As an average over the last 5 years, CPRX stock has a PE ratio of 15.46.
What is the highest PE ratio for CPRX?
Over the last six years, the quarterly PE ratio reached a historic high of 59 in the Sep 2019 quarter.
How does the current PE ratio for CPRX compare to its historical average?
The current price to earnings ratio of CPRX is 6% higher than the 6-year historical average.
How is CPRX's PE ratio calculated (Catalyst Pharmaceuticals PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Feb 4, 2025), Catalyst Pharmaceuticals's stock price is $23.09. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.25. Therefore, Catalyst Pharmaceuticals's price to earnings ratio for today is 18.47. PE RATIO(18.47) = STOCK PRICE($23.09) / TTM EPS($1.25)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.